| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| uniQure N.V. | Chief Legal Officer | Ordinary Shares | 91.8K | $457K | $4.98 | Jun 13, 2024 | Direct |
| uniQure N.V. | Chief Legal Officer | Stock Option (Right to Buy) | 85.5K | Mar 1, 2024 | Direct | ||
| Forma Therapeutics Holdings, Inc. | Officer Title: SVP, General Counsel and Corporate Secretary | Common Stock | 0 | $5.05 | Oct 14, 2022 | Direct | |
| Forma Therapeutics Holdings, Inc. | Officer Title: SVP, General Counsel and Corporate Secretary | Stock Option (Right to Buy) | 0 | Oct 14, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| QURE | uniQure N.V. | Jun 13, 2024 | 1 | -$23.8K | 4 | Jun 17, 2024 | Chief Legal Officer |
| QURE | uniQure N.V. | Mar 1, 2024 | 2 | $0 | 4 | Mar 5, 2024 | Chief Legal Officer |
| QURE | uniQure N.V. | Jun 13, 2023 | 2 | $0 | 4 | Jun 15, 2023 | Chief Legal and Compliance Officer |
| QURE | uniQure N.V. | Jun 13, 2023 | 0 | $0 | 3 | Jun 15, 2023 | Officer Title: Chief Legal and Compliance Officer. Exhibit List: Exhibit 24 - Power of Attorney |
| FMTX | Forma Therapeutics Holdings, Inc. | Oct 14, 2022 | 8 | $0 | 4 | Oct 14, 2022 | Officer Title: SVP, General Counsel and Corporate Secretary |
| FMTX | Forma Therapeutics Holdings, Inc. | Feb 28, 2022 | 2 | $0 | 4 | Mar 2, 2022 | Officer Title: SVP, General Counsel and Corporate Secretary |
| FMTX | Forma Therapeutics Holdings, Inc. | Feb 23, 2022 | 1 | -$45.7K | 4 | Feb 25, 2022 | Officer |